Trial intelligence / Profile preview

Lixisenatide Effects in Pancreatectomised Subjects

NCT02640118Completed

Sponsor
Gentofte Hospital
Start
Aug 2015
Primary completion
Jul 2016
Modality
Peptides
01

Overview

Randomised, double-blind trial of lixisenatide in postpancreatectomy diabetes mellitus (2 cohorts), sponsored by Gentofte Hospital. Primary endpoint: Postprandial Glucose Excursions (Incremental Area Under Curve) at 180 minutes. Started Aug 2015; status: completed.

02

Drugs

lixisenatide
03

Conditions

postpancreatectomy diabetes mellitus

Beyond the preview

Go deeper on NCT02640118.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02640118.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call